Teva's AirDuo steps up to challenge Advair, but the newcomer's fate depends on price | Fierce Pharma
Teva 59310057922 - McKesson Medical-Surgical
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
Teva Pharmaceuticals Europe - Home | Facebook
Teva Pharmaceuticals and IBM Partner to Build Global e-Health Solutions on the IBM Watson Health Cloud
Teva's Respiratory Drugs Contribute 11% to Specialty Medicines
Teva Q3 profit misses estimates, tightens FY19 forecast | AlphaStreet
Articles about Teva Pharmaceuticals
Teva Pharmaceuticals buys smart inhaler company Gecko Health Innovations | MobiHealthNews
Teva Announces Unique Collaboration with HealthSnap to Expand the Reach of its Respiratory Digital Health Platform | Business Wire
Teva Pharmaceutical: What To Expect In 2023 With New CEO (NYSE:TEVA) | Seeking Alpha
Teva's Unorthodox Strategy For The Respiratory Market — Will It Work
David Tapp - US Respiratory HCP Marketing - Teva Pharmaceuticals | LinkedIn
Teva Pharmaceuticals Announces Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America
Teva launches connected inhaler for asthma, COPD - Drug Delivery Business
Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ | SnackSafely.com
Teva Develops First FDA-Approved Digitally-Integrated Inhaler
Teva Pharmaceuticals buys smart inhaler company Gecko Health Innovations | MobiHealthNews
Teva to expand respiratory portfolio with MicroDose Therapeutx acquisitions - Medical Device Network
Teva, Rimidi expand collaboration with respiratory monitoring programme
The World of the API Podcast: Respiratory APIs | Teva api
